CCL7 and vascular neoplasm: CCBP2 is a promiscuous receptor [37], binds to SCYA2/MCP-1, SCY3/MIP-1-ALPHA, SCYA5/RANTES AND SCYA7/MCP-3. CCBP2 is expressed in the lymphatic endothelium, a subset of vascular tumors [37] and melanoma cells [38].